A study of immunocompromised patients undergoing bone marrow transplants and given fluconazole as a “just in case” measure developed an increase in candida krusei colonies. This led led the researchers, writing in the New England Journal of Medicine (31 October 1991) to conclude that in patients at high risk for “disseminated candida infections” suppression of bacterial flora and more common candida pathogens “may permit some less pathogenic, but natively resistant candida species. . . to emerge as systemic pathogens.”

What this could mean is that killing off candida albicans further disrupts the bowel flora, allowing other bugs to grow.Another unexplained phenomenon is that women who take oral Nystatin for systemic candida seem to suffer an increase in vaginal candida. But it could well be that the anti fungal disrupts the vaginal balance further, paving the way for the overrunning of other pathogens.

What Doctors Don't Tell You Written by What Doctors Don't Tell You

We Humbly Recommend

Get the Healthiest Newsletter!

Get a dose of Healthy delivered straight to your inbox. Each FREE issue features amazing content that will elevate your Body, Mind, and Spirit.

Your data is never shared with 3rd parties


Healthy Shopping

Health and Wellbeing products lovingly curated for you.